Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.
about
High Plasma Glucagon Levels Correlate with Waist-to-Hip Ratio, Suprailiac Skinfold Thickness, and Deep Subcutaneous Abdominal and Intraperitoneal Adipose Tissue Depots in Nonobese Asian Indian Males with Type 2 Diabetes in North IndiaFertility and pregnancy-associated ß-cell proliferation in mice deficient in proglucagon-derived peptidesAristaless-related homeobox plays a key role in hyperplasia of the pancreas islet α-like cells in mice deficient in proglucagon-derived peptidesAssociation of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity.Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides.cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocinThe selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.Regulation of amino acid metabolism and alpha cell proliferation by glucagon.The biology of glucagon and the consequences of hyperglucagonemia.A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
P2860
Q33786795-62E57139-5959-4D72-B008-F9E2B621184CQ34395967-8CDF7E56-EA69-4883-BBF5-3328593D67B6Q34721371-26AEBFC5-1C78-4936-8BDD-617B95C17332Q35153027-EB432917-FE2A-4627-864F-293575C23A88Q35778163-AA9FCD8F-8AEB-4423-AADF-2B33477428D8Q36560559-5041E44B-48BB-487A-988D-790EC08633DDQ36890766-F58C269F-2715-4125-93E5-A507518F512CQ36990110-5A6C2CA4-8D3C-4AD5-9FE5-59BFBBD59068Q39152510-5930191D-FC3D-434E-AB0E-8213C33987CFQ41197445-514B6AAC-8376-4138-A51A-EF61DB3F32CBQ47190965-732151AF-450B-49AA-ACC7-C17FB61DC0B7Q51525761-404A835C-1C82-4E0B-9289-BE13C13CD3D2Q51747259-2FF6D5C6-60A3-41A6-99CB-A686436B900AQ53744774-3E6076BD-460E-475A-9143-C6302F796866Q58732217-FFD57EB2-B994-4575-A28D-6CDE74BBE62F
P2860
Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@ast
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@en
type
label
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@ast
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@en
prefLabel
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@ast
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@en
P2093
P2860
P356
P1433
P1476
Remodeling of hepatic metaboli ...... proglucagon-derived peptides.
@en
P2093
Ayako Fukami
Chika Watanabe
Hiroki Miyahira
Katsumi Shibata
Michiyo Yamamoto
Nobuaki Ozaki
Tsutomu Fukuwatari
Yoshiharu Murata
Yoshiko Takagishi
P2860
P356
10.2337/DB11-0739
P407
P577
2012-01-01T00:00:00Z